Obesity Drug Prices Are Dropping, but Getting a Steady Supply Remains a Challenge

(MedPage Today) — Prices are falling for the popular obesity treatments semaglutide (Wegovy) and tirzepatide (Zepbound), but steady access to the drugs remains challenging.
The medications still amount to around $500 per month for those without…